Table 4 Proportion of patients with correct diagnoses linked to the prescribed drugs
Antipsychotics | Proton pump inhibitors | Digoxin | Loop diuretics | Serotonin reuptake inhibitors | |
|---|---|---|---|---|---|
Gender | |||||
Male | 17.4 % (156/898) | 12.9 % (664/5149) | 78.2 % (1080/1381) | 70.9 % (4581/6460) | 39.2 % (1035/2641) |
Female | 18.3 % (311/1703) | 12.9 % (1010/7853) | 73.9 % (1315/1780) | 67.9 % (6878/10137) | 40.8 % (2570/6298) |
Age | |||||
65-79 | 21.7 % (248/1143) | 13.6 % (1077/7894) | 78.2 % (921/1178) | 69.5 % (4971/7157) | 45.8 % (2130/4655) |
80+ | 15.0 %* (219/1458) | 11.7 %* (597/5108) | 74.3 % (1474/1983) | 68.7 % (6488/9440) | 34.4 %* (1475/4284) |
Multimorbidity level | |||||
RUBa 3 (low) | 20.7 % (258/1244) | 14.3 % (1032/7234) | 79.5 % (1327/1669) | 71.3 % (6187/8683) | 44.3 % (2042/4608) |
RUB 4 | 23.8 % (114/479) | 12.5 % (253/2028) | 89.6 % (583/651) | 81.2 %* (2439/3005) | 46.3 % (688/1486) |
RUB 5 (high) | 19.6 % (46/235) | 14.5 % (141/971) | 93.5 % (272/291) | 86.5 %* (1162/1344) | 46.9 % (323/689) |
Income level | |||||
1 (low) | 13.4 % (128/953) | 12.7 % (454/3577) | 76.1 % (669/879) | 68.8 % (3367/4895) | 38.4 % (998/2602) |
2 | 18.7 %* (159/851) | 13.0 % (451/3481) | 72.9 % (679/932) | 67.4 % (3433/5092) | 39.4 % (1054/2673) |
3 | 24.4 %* (118/484) | 13.1 % (427/3263) | 76.3 % (595/780) | 70.3 % (2893/4118) | 42.6 % (881/2067) |
4 (high) | 19.8 %* (62/313) | 12.8 % (342/2681) | 79.3 % (452/570) | 70.9 % (1766/2492) | 42.1 % (672/1597) |